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Angioplasty of the hand arteries in critical hand ischaemia.
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Background: Critical hand ischaemia (CHI) of the upper extremity is rarely encountered.
Axillary, brachial and below-the-elbow (BTE) disease is often asymptomatic due to
highly developed collaterals, but in diffuse- multiple and thrombotic disease CHI can
develop. The aim of this prospective study was to assess the feasibility, safety and
outcomes of percutaneous transluminal angioplasty (PTA) in the treatment of CHI.
Methods: Twenty-one patients (age 72  13 years; six females) were treated with
angioplasty in 2011 (16 pain at rest; 2 non-healing ulcer; 3 gangrene) due to axillary-
brachial and pure BTE artery disease. We examined the procedural and clinical success
and the rate of major adverse events (MAE) and vascular complications.
Results: One patient had Takayasu arteritis and 3 patients had symptomatic radial artery
occlusion after transradial PCI in the investigated population. Six patients (n6, 29%) had
subacute occlusion and 11 patients had chronic disease (n15, 71%). Multilevel (n8,
38%), unilevel dilatations (13, 62%) and in 3 cases parallel dilatations were performed
(n3, 14%). Angioplasty was performed in the axillary (n6), brachial (n12), radial
(n5), ulnar (n8), interosseus (n1) and in palmar arch (n2). Technical success rate
was 95% (20/21). Successful mechanical (Rotarex, n1, 17%) and aspiration thrombec-
tomy (n5, 83%) was performed in subacute cases, before angioplasty (n6, 100%) and
stenting (n3, 50%). In chronic cases angioplasty was performed in all cases (15, 100%)
and additional stenting was necessary in 6 cases (40%). PTA was unsuccessful in one
patient (1/21, 5%). The hand-healing rate in the patients with gangrene and non-healing
ulcer was 100% (5/5), and the relief of the pain was observed in 20 patients (20/21, 95%).
Two patients (n2, 9.5%) underwent secondary procedures due to symptomatic reste-
nosis. The MAE rate was 0% during follow-up. One vascular complication (5%) occurred
in the investigated population (radial artery perforation successfully treated with com-
pression bandage).
Conclusions: Angioplasty of the hand vessels for CHI is a feasible and safe procedure
with acceptable rates of technical success and hand healing.
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Acute Outcomes For A Below The Knee Use Of A Novel Balloon Catheter
First In Man Clinical Study
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Background: The Chocolate FIM Study will confirm device safety and assess the
occurrence of vascular and procedural complications after treatment with the novel
Chocolate PTA Balloon Catheter.
Methods: Angioplasty for peripheral vascular disease is often associated with acute
complications following inflation and deflation of a standard balloon. Such complications
are commonly considered to be related to vessel trauma and often require bailout stenting.
The Chocolate PTA Balloon Catheter (developed by Quattro Vascular, Singapore/
distributed by TriReme Medical, CA) is a novel balloon catheter with a mounted
constraining structure to allow for uniform inflation and rapid deflation. The attributes of
the constrained balloon are designed for modulated dilatation and creation of small balloon
segments (“pillows”), intended to minimize vessel damage. The first in man use of this novel
device is described here. Acute assessments include: technical success (50% residual
stenosis without flow-limiting dissection), rate of bailout stenting, and occurrence/severity of
dissection and the occurrence of in-hospital major adverse events (MAE- defined as TLR,
death, or major amputation). All treatment angiograms are independently reviewed by a core
lab to confirm vascular outcomes after treatment with the Chocolate Balloon. Clinical and
Duplex Ultrasound follow-up at 1, 6, and 12 months is on-going.
Results: The Chocolate Balloon has been used in the first 22 patients (58% CLI) to treat BTK
target lesions (average length 11cm). The Chocolate device was used successfully in a diverse
range of BTK vessels (AT (48%), PER (14%), Trunk only (14%), Trunk to PER (14%), Trunk
to PT (5%), PT (3%)). Acute results include successful delivery and deployment in all cases.
Technical Success is 100%. Bail-out stenting is 0%. No flow- limiting dissection has been
reported for any Chocolate case. No in-hospital or 30 day MAEs has been reported. 6 Month
MAE and Patency data will be included in presentation.
Conclusions: These initial cases verify that the Chocolate Balloon is safe for use. These
early data also present compelling evidence to suggest that the design of the Chocolate
Balloon is effective in reducing proced.
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TASC II Type C/D Lesions. Mid to long term Clinical outcome
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Background: Of 1076 patients referred with PVD from 2002 to 2007, 206 SIAs in 190
patients and 128 bypass grafts in 119 patients were enrolled in the study. All patients had
rest pain and/or tissue loss.
Methods: Primary endpoints were survival free from amputation and sustained clinical
improvement. Secondary endpoints were major adverse events (MAE), the binary
restenosis rate, freedom from TLR, and a special quality-adjusted life year (QALY)
endpoint (Q-TWiST) that incorporated both length and quality of life to evaluate
treatments.
Results: At 5 years, clinical improvement was sustained in 82.8% of the SIA group
versus 68.2% of the BG patients (p50.106). Five-year all-cause survival was similar for
SIA (78.6%) and BG (80.1%; p0.734), as was amputation-free survival (SIA 72.9%
versus BG 71.2%;p0.976). Hyperfibrinogenemia (p0.009) and C-reactive protein
(p0.019) had negative effects on survival without amputation. Five-year freedom from
binary restenosis rates were 72.8% for SIA versus 65.3% for BG (p0.700). While the
5-year freedom from TLR rates (SIA 85.9% versus BS 72.1%, p0.262) were not
statistically significant, the risk of MAE (p0.002) and length of hospital stay (p0.0001)
were significantly reduced. Q-TWiST significantly improved (p0.001) and cost-per-
QALY was reduced with SIA. The 5-year risk of re-intervention (p0.05) and mean
number of procedures (p0.078) were similar.
Conclusions: Five-year freedom from MAE was enhanced by 20% in the SIA group,
with substantial cost reduction and better Q-TWiST. SIA is a minimally invasive
technique that expands amputation-free and symptom-free survival. SIA is a paradigm
shift in the management of CLI.
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Background: Lower ankle-brachial index (ABI) was associated with increasing coro-
nary artery disease (CAD) risk and poor prognosis. But the association between the
severity of CAD and the level of ABI has not been clear. We conducted this study to
evaluate the association between the severity of CAD and the level of ABI.
Methods: We prospectively enrolled 2,531 consecutive patients who admitted for
coronary angiography. All patients underwent ABI during hospitalization period. We
classified as Group I (normal ABI defined as0.9), Group II (mildly low ABI defined as
0.71-0.9), Group III (moderately low ABI defined as 0.41-0.7) and Group IV (severely
low ABI defined as 0.41).,according to ABI values.
Results: The mean age was 62.89.2. The distribution of severity of coronary artery
disease were normal (n314, 12.4%), 1-vessel (n728, 28.8%), 2-vessel (n570,
22.5%) and 3-vessel disease (n919, 36.3%). Among them, Group I (n2,178, 86.1%),
Group II (n156, 6.2%), Group III (n170, 6.7%) and Group IV (n27, 1.1%) were
identified. Multiple linear regression analysis showed that ABI was significantly associ-
ated with the severity of CAD (SE0.130.04, p0.001). The lower ABI group






n % n % n % n %
Group I 290 13.3 666 30.6 499 22.9 723 33.2
Group II 16 10.3 29 18.6 27 17.3 84 53.8
Group III 8 4.7 29 17.1 39 22.9 94 55.3
Group IV 0 0.0 4 14.8 5 18.5 18 66.7
p0.001
Conclusions: The lower level of ABI was strongly associated with more severe CAD.
The ABI might be a valuable indicator of severity of CAD.
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Relationship between improvement of skin perfusion pressure, clinical
outcomes and wound blush after successful endovascular treatment
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Background: Several reports have been published of the acceptable patency and limb
salvage rates following infra-popliteal interventions for the treatment of critical limb
ischemia (CLI). However, the optimal angiographic endpoint of endovascular therapy
(EVT) remains unclear. The aim of this study was to assess the relationship between the
appearance of wound blush as an angiographic endpoint, improvement of skin perfusion
pressure (SPP) and clinical outcomes.
Methods: “Wound blush” was defined as contrast opacification of the vessels around the
wound in digital subtraction angiograms obtained immediately after the EVT through the
catheter introduced into the popliteal artery. We analyzed the data of 77 consecutive
patients (93 limbs) with ischemic ulcerations classified as Rutherford category 5 or 6, who
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